How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
-H.R. 1319, American Rescue Plan, support dedicated funding for Medicaid home- and community-based services; including adult dependents in Economic Impact Payments; extension of emergency paid leave tax credits; and provisions to improve affordability of health coverage including subsidizing premium costs for those on COBA and increasing subsidies to purchase coverage through the Affordable Care Act. -Oppose weakening of Medicares Six Protected Classes contained in Calendar Year 2022 Request for Applications for the Part D Payment Modernization Model. -S. 464, Safe Step Act, support passage. -S. 253, Marihuana Research Expansion Act and Medical Marijuana Research Act, support passage.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
EPILEPSY FOUNDATION via EPILEPSY FOUNDATION
2021 · third_quarter · Q3
-H.R. 4502, Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2022, support funding for epilepsy programs and research including $13 million for the CDCs Epilepsy program, $46.1 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System. -H.R.4355, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022, support $13 million for the VA Epilepsy Centers of Excellence. -H.R. 4356, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2022, support robust funding for the Food & Drug Administration. -H.R. 4432, Defense Appropriations Act, 2022, support robust funding for the Congressionally Directed Medical Research Programs.
Source: Senate LDA
-Build Back Better Act, support $400 billion for Medicaid home- and community-based services; addressing affordability of health insurance premiums; creating an out-of-pocket cap in Medicare Part D with smoothing mechanism; bar use of discriminatory quality-adjusted life year (QALY) in prescription drug legislation; preserving the Orphan Drug Tax Credit; creating a comprehensive paid family and medical leave program; adding vision, dental, and hearing coverage to Medicare; raising asset limits and other improvements to supplemental security income; expanding low-income subsidies in Medicare. -Ensure access to medications in emergencies in pandemic preparedness legislation. -HCBS Access Act, support development of legislation that would make Medicaid HCBS mandatory, end the waiting list, enhance HCBS services, and provide proper support to the direct support workforce. -S. 464/H.R. 2163, Safe Step Act, support passage. -S. 253, Marihuana Research Expansion Act and Medical Marijuana Research Act, support passage. -Identify and make recommendations on improvements to federal law for access to medical cannabis and medical cannabis products. -Support creation of a Neuroscience Center of Excellence at the FDA.
-Address affordability of health insurance premiums, out-of-pocket costs, support and expand Medicaid coverage and limit inadequate short-term limited duration and other non-compliant plans. -Create an out-of-pocket cap in Medicare Part D with smoothing mechanism, bar use of discriminatory quality-adjusted life year (QALY) in prescription drug legislation; improve Medicare coverage for low income beneficiaries; add vision, dental, and hearing coverage to Medicare -Include provisions ensuring access to medications in emergencies in pandemic preparedness legislation -S. 2210, Better Care Better Jobs Act, support passage to enhance funding for and expand access to Medicaid home- and community-based services (HCBS) and permanently reauthorize Money Follows the Person -HCBS Access Act, support development of legislation that would make Medicaid HCBS mandatory, end the waiting list, enhance HCBS services, and provide proper support to the direct support workforce. -Provide a $400 billion investment in Medicaid home-and community-based services (HCBS) as outlined in the Build Back Better Agenda -S. 464/H.R. 2163, Safe Step Act, support passage -S. 253, Marihuana Research Expansion Act and Medical Marijuana Research Act, support passage -Identify and make recommendations on improvements to federal law for access to medical cannabis and medical cannabis products.
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 4502, Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2022, support funding for epilepsy programs and research including $13 million for the CDCs Epilepsy program, $46.1 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System. -H.R.4355, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022, support $13 million for the VA Epilepsy Centers of Excellence. -H.R. 4356, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2022, support robust funding for the Food & Drug Administration. -H.R. 4432, Defense Appropriations Act, 2022, support robust funding for the Congressionally Directed Medical Research Programs.
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 4502, Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2022, support funding for epilepsy programs and research including $13 million for the CDCs Epilepsy program, $46.1 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System. -H.R.4355, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022, support $13 million for the VA Epilepsy Centers of Excellence. -H.R. 4356, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2022, support robust funding for the Food & Drug Administration. -H.R. 4432, Defense Appropriations Act, 2022, support robust funding for the Congressionally Directed Medical Research Programs.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 4502, Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2022, support funding for epilepsy programs and research including $13 million for the CDCs Epilepsy program, $46.1 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System. -H.R.4355, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022, support $13 million for the VA Epilepsy Centers of Excellence. -H.R. 4356, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2022, support robust funding for the Food & Drug Administration. -H.R. 4432, Defense Appropriations Act, 2022, support robust funding for the Congressionally Directed Medical Research Programs.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 4502, Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2022, support funding for epilepsy programs and research including $13 million for the CDCs Epilepsy program, $46.1 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System. -H.R.4355, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022, support $13 million for the VA Epilepsy Centers of Excellence. -H.R. 4356, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2022, support robust funding for the Food & Drug Administration. -H.R. 4432, Defense Appropriations Act, 2022, support robust funding for the Congressionally Directed Medical Research Programs.
Department of Defense Appropriations Act, 2022
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 4502, Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2022, support funding for epilepsy programs and research including $13 million for the CDCs Epilepsy program, $46.1 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System. -H.R.4355, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022, support $13 million for the VA Epilepsy Centers of Excellence. -H.R. 4356, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2022, support robust funding for the Food & Drug Administration. -H.R. 4432, Defense Appropriations Act, 2022, support robust funding for the Congressionally Directed Medical Research Programs.
Department of Defense Appropriations Act, 2022
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 4502, Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2022, support funding for epilepsy programs and research including $13 million for the CDCs Epilepsy program, $46.1 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System. -H.R.4355, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022, support $13 million for the VA Epilepsy Centers of Excellence. -H.R. 4356, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2022, support robust funding for the Food & Drug Administration. -H.R. 4432, Defense Appropriations Act, 2022, support robust funding for the Congressionally Directed Medical Research Programs.
Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 4502, Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2022, support funding for epilepsy programs and research including $13 million for the CDCs Epilepsy program, $46.1 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System. -H.R.4355, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022, support $13 million for the VA Epilepsy Centers of Excellence. -H.R. 4356, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2022, support robust funding for the Food & Drug Administration. -H.R. 4432, Defense Appropriations Act, 2022, support robust funding for the Congressionally Directed Medical Research Programs.
Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 4502, Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2022, support funding for epilepsy programs and research including $13 million for the CDCs Epilepsy program, $46.1 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System. -H.R.4355, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022, support $13 million for the VA Epilepsy Centers of Excellence. -H.R. 4356, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2022, support robust funding for the Food & Drug Administration. -H.R. 4432, Defense Appropriations Act, 2022, support robust funding for the Congressionally Directed Medical Research Programs.
-Address affordability of health insurance premiums, out-of-pocket costs, support and expand Medicaid coverage and limit inadequate short-term limited duration and other non-compliant plans. -Create an out-of-pocket cap in Medicare Part D with smoothing mechanism, bar use of discriminatory quality-adjusted life year (QALY) in prescription drug legislation; improve Medicare coverage for low income beneficiaries; add vision, dental, and hearing coverage to Medicare -Include provisions ensuring access to medications in emergencies in pandemic preparedness legislation -S. 2210, Better Care Better Jobs Act, support passage to enhance funding for and expand access to Medicaid home- and community-based services (HCBS) and permanently reauthorize Money Follows the Person -HCBS Access Act, support development of legislation that would make Medicaid HCBS mandatory, end the waiting list, enhance HCBS services, and provide proper support to the direct support workforce. -Provide a $400 billion investment in Medicaid home-and community-based services (HCBS) as outlined in the Build Back Better Agenda -S. 464/H.R. 2163, Safe Step Act, support passage -S. 253, Marihuana Research Expansion Act and Medical Marijuana Research Act, support passage -Identify and make recommendations on improvements to federal law for access to medical cannabis and medical cannabis products.
Cannabidiol and Marihuana Research Expansion Act
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-Build Back Better Act, support $400 billion for Medicaid home- and community-based services; addressing affordability of health insurance premiums; creating an out-of-pocket cap in Medicare Part D with smoothing mechanism; bar use of discriminatory quality-adjusted life year (QALY) in prescription drug legislation; preserving the Orphan Drug Tax Credit; creating a comprehensive paid family and medical leave program; adding vision, dental, and hearing coverage to Medicare; raising asset limits and other improvements to supplemental security income; expanding low-income subsidies in Medicare. -Ensure access to medications in emergencies in pandemic preparedness legislation. -HCBS Access Act, support development of legislation that would make Medicaid HCBS mandatory, end the waiting list, enhance HCBS services, and provide proper support to the direct support workforce. -S. 464/H.R. 2163, Safe Step Act, support passage. -S. 253, Marihuana Research Expansion Act and Medical Marijuana Research Act, support passage. -Identify and make recommendations on improvements to federal law for access to medical cannabis and medical cannabis products. -Support creation of a Neuroscience Center of Excellence at the FDA.
Cannabidiol and Marihuana Research Expansion Act
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 1319, American Rescue Plan, support dedicated funding for Medicaid home- and community-based services; including adult dependents in Economic Impact Payments; extension of emergency paid leave tax credits; and provisions to improve affordability of health coverage including subsidizing premium costs for those on COBA and increasing subsidies to purchase coverage through the Affordable Care Act. -Oppose weakening of Medicares Six Protected Classes contained in Calendar Year 2022 Request for Applications for the Part D Payment Modernization Model. -S. 464, Safe Step Act, support passage. -S. 253, Marihuana Research Expansion Act and Medical Marijuana Research Act, support passage.
Cannabidiol and Marihuana Research Expansion Act
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-Address affordability of health insurance premiums, out-of-pocket costs, support and expand Medicaid coverage and limit inadequate short-term limited duration and other non-compliant plans. -Create an out-of-pocket cap in Medicare Part D with smoothing mechanism, bar use of discriminatory quality-adjusted life year (QALY) in prescription drug legislation; improve Medicare coverage for low income beneficiaries; add vision, dental, and hearing coverage to Medicare -Include provisions ensuring access to medications in emergencies in pandemic preparedness legislation -S. 2210, Better Care Better Jobs Act, support passage to enhance funding for and expand access to Medicaid home- and community-based services (HCBS) and permanently reauthorize Money Follows the Person -HCBS Access Act, support development of legislation that would make Medicaid HCBS mandatory, end the waiting list, enhance HCBS services, and provide proper support to the direct support workforce. -Provide a $400 billion investment in Medicaid home-and community-based services (HCBS) as outlined in the Build Back Better Agenda -S. 464/H.R. 2163, Safe Step Act, support passage -S. 253, Marihuana Research Expansion Act and Medical Marijuana Research Act, support passage -Identify and make recommendations on improvements to federal law for access to medical cannabis and medical cannabis products.
-H.R. 1319, American Rescue Plan, support dedicated funding for Medicaid home- and community-based services; including adult dependents in Economic Impact Payments; extension of emergency paid leave tax credits; and provisions to improve affordability of health coverage including subsidizing premium costs for those on COBA and increasing subsidies to purchase coverage through the Affordable Care Act. -Oppose weakening of Medicares Six Protected Classes contained in Calendar Year 2022 Request for Applications for the Part D Payment Modernization Model. -S. 464, Safe Step Act, support passage. -S. 253, Marihuana Research Expansion Act and Medical Marijuana Research Act, support passage.
-Address affordability of health insurance premiums, out-of-pocket costs, support and expand Medicaid coverage and limit inadequate short-term limited duration and other non-compliant plans. -Create an out-of-pocket cap in Medicare Part D with smoothing mechanism, bar use of discriminatory quality-adjusted life year (QALY) in prescription drug legislation; improve Medicare coverage for low income beneficiaries; add vision, dental, and hearing coverage to Medicare -Include provisions ensuring access to medications in emergencies in pandemic preparedness legislation -S. 2210, Better Care Better Jobs Act, support passage to enhance funding for and expand access to Medicaid home- and community-based services (HCBS) and permanently reauthorize Money Follows the Person -HCBS Access Act, support development of legislation that would make Medicaid HCBS mandatory, end the waiting list, enhance HCBS services, and provide proper support to the direct support workforce. -Provide a $400 billion investment in Medicaid home-and community-based services (HCBS) as outlined in the Build Back Better Agenda -S. 464/H.R. 2163, Safe Step Act, support passage -S. 253, Marihuana Research Expansion Act and Medical Marijuana Research Act, support passage -Identify and make recommendations on improvements to federal law for access to medical cannabis and medical cannabis products.
-Build Back Better Act, support $400 billion for Medicaid home- and community-based services; addressing affordability of health insurance premiums; creating an out-of-pocket cap in Medicare Part D with smoothing mechanism; bar use of discriminatory quality-adjusted life year (QALY) in prescription drug legislation; preserving the Orphan Drug Tax Credit; creating a comprehensive paid family and medical leave program; adding vision, dental, and hearing coverage to Medicare; raising asset limits and other improvements to supplemental security income; expanding low-income subsidies in Medicare. -Ensure access to medications in emergencies in pandemic preparedness legislation. -HCBS Access Act, support development of legislation that would make Medicaid HCBS mandatory, end the waiting list, enhance HCBS services, and provide proper support to the direct support workforce. -S. 464/H.R. 2163, Safe Step Act, support passage. -S. 253, Marihuana Research Expansion Act and Medical Marijuana Research Act, support passage. -Identify and make recommendations on improvements to federal law for access to medical cannabis and medical cannabis products. -Support creation of a Neuroscience Center of Excellence at the FDA.
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage.
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420/S. 3652 All Dependents Count Act, support passage. -H.R. 6680/S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305/S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage. -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless. -H.R. 2093/S. 1028, STATES Act, support passage. -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage. -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage.
-H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, support funding for agencies like the NIH, FDA and CDC to research, better treat and raise awareness and education about COVID-19, as well as support providing authority to relax restrictions in Medicare for telehealth services and reimbursement. -H.R. 6201, Families First Coronavirus Response Act, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs; funding for agencies to research, better treat and raise awareness and education about COVID-19; expansion of paid sick leave and paid family and medical leave; and free COVD-19 testing regardless of insurance type. -H., CR. 748, CARES Act, support various provisions relevant to people with epilepsy and nonprofit support including access of up to a 90-day supply of medications through the pandemic; funding for agencies to research, better treat and raise awareness and education about COVID-19; prohibiting waivers of the Individuals with Disabilities Education Act (IDEA) and providing funding to ensure that special education needs are met through the pandemic; eligibility of Social Security beneficiaries for Economic Impact Payments and payments for Social Security beneficiaries without filing tax returns; grants to providers of Home and Community-Based Services; and allowing 501(c)(3) organizations and organizations that provide Medicaid services to apply for small business loans. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3, Elijah Cummings Lower Drug Costs Now Act, support specific provisions such as an out-of-pocket cap in Medicare Part D and addition of language to ban the use of QALYs -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -S. 2543, the Prescription Drug Pricing Reduction Act of 2019, support specific provisions such as an out-of-pocket cap in Medicare and improvements to the Medicaid Drug Rebate Program, as well as permanent authorization of the Money Follows the Person program. (Nicole and I did a bunch of these visits together since the two issues got linked). -S. 1895, Lower Health Care Costs Act, support provisions to increase transparency and address anticompetitive practices in the prescription drug market -H.R. 712, VA Medicinal Cannabis Research Act, support addition of epilepsy -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -FDA-2019-N-1428, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, support preservation of meaningful access to cannabis and cannabis-derived products, including CBD tinctures with therapeutic levels of the cannabinoid, and creation of a regulatory framework that ensures that there is consistency in available products, manufacturing, safety, testing, and labeling standards, and increases the availability of important information such as potential side effects and drug interactions so that consumers and practitioners may be better informed -H.R. 2035/S. 995, Lifespan Respite Reauthorization Act, support passage.
-H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage-H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless-H.R. 2093/S. 1028, STATES Act, support passage-H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage- H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.
Consolidated Appropriations Act, 2021
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage-H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless-H.R. 2093/S. 1028, STATES Act, support passage-H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage- H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.
Consolidated Appropriations Act, 2021
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 7614, Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2021, support funding for epilepsy programs and research including $11.5 million for the CDCs Epilepsy program, $44.7 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System, and $10 million for Lifespan Respite Care Program -H.R. 7610, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2021, support robust funding for the Food & Drug Administration. -H.R. 7617, Defense Appropriations Act, 2021, support robust funding for the Congressionally Directed Medical Research Programs. -H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.
Patient Protection and Affordable Care Enhancement Act
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage-H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless-H.R. 2093/S. 1028, STATES Act, support passage-H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage- H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.
Patient Protection and Affordable Care Enhancement Act
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage.
Lifespan Respite Care Reauthorization Act of 2019
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, support funding for agencies like the NIH, FDA and CDC to research, better treat and raise awareness and education about COVID-19, as well as support providing authority to relax restrictions in Medicare for telehealth services and reimbursement. -H.R. 6201, Families First Coronavirus Response Act, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs; funding for agencies to research, better treat and raise awareness and education about COVID-19; expansion of paid sick leave and paid family and medical leave; and free COVD-19 testing regardless of insurance type. -H., CR. 748, CARES Act, support various provisions relevant to people with epilepsy and nonprofit support including access of up to a 90-day supply of medications through the pandemic; funding for agencies to research, better treat and raise awareness and education about COVID-19; prohibiting waivers of the Individuals with Disabilities Education Act (IDEA) and providing funding to ensure that special education needs are met through the pandemic; eligibility of Social Security beneficiaries for Economic Impact Payments and payments for Social Security beneficiaries without filing tax returns; grants to providers of Home and Community-Based Services; and allowing 501(c)(3) organizations and organizations that provide Medicaid services to apply for small business loans. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3, Elijah Cummings Lower Drug Costs Now Act, support specific provisions such as an out-of-pocket cap in Medicare Part D and addition of language to ban the use of QALYs -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -S. 2543, the Prescription Drug Pricing Reduction Act of 2019, support specific provisions such as an out-of-pocket cap in Medicare and improvements to the Medicaid Drug Rebate Program, as well as permanent authorization of the Money Follows the Person program. (Nicole and I did a bunch of these visits together since the two issues got linked). -S. 1895, Lower Health Care Costs Act, support provisions to increase transparency and address anticompetitive practices in the prescription drug market -H.R. 712, VA Medicinal Cannabis Research Act, support addition of epilepsy -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -FDA-2019-N-1428, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, support preservation of meaningful access to cannabis and cannabis-derived products, including CBD tinctures with therapeutic levels of the cannabinoid, and creation of a regulatory framework that ensures that there is consistency in available products, manufacturing, safety, testing, and labeling standards, and increases the availability of important information such as potential side effects and drug interactions so that consumers and practitioners may be better informed -H.R. 2035/S. 995, Lifespan Respite Reauthorization Act, support passage.
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420/S. 3652 All Dependents Count Act, support passage. -H.R. 6680/S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305/S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage. -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless. -H.R. 2093/S. 1028, STATES Act, support passage. -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage. -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage.
-H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, support funding for agencies like the NIH, FDA and CDC to research, better treat and raise awareness and education about COVID-19, as well as support providing authority to relax restrictions in Medicare for telehealth services and reimbursement. -H.R. 6201, Families First Coronavirus Response Act, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs; funding for agencies to research, better treat and raise awareness and education about COVID-19; expansion of paid sick leave and paid family and medical leave; and free COVD-19 testing regardless of insurance type. -H., CR. 748, CARES Act, support various provisions relevant to people with epilepsy and nonprofit support including access of up to a 90-day supply of medications through the pandemic; funding for agencies to research, better treat and raise awareness and education about COVID-19; prohibiting waivers of the Individuals with Disabilities Education Act (IDEA) and providing funding to ensure that special education needs are met through the pandemic; eligibility of Social Security beneficiaries for Economic Impact Payments and payments for Social Security beneficiaries without filing tax returns; grants to providers of Home and Community-Based Services; and allowing 501(c)(3) organizations and organizations that provide Medicaid services to apply for small business loans. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3, Elijah Cummings Lower Drug Costs Now Act, support specific provisions such as an out-of-pocket cap in Medicare Part D and addition of language to ban the use of QALYs -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -S. 2543, the Prescription Drug Pricing Reduction Act of 2019, support specific provisions such as an out-of-pocket cap in Medicare and improvements to the Medicaid Drug Rebate Program, as well as permanent authorization of the Money Follows the Person program. (Nicole and I did a bunch of these visits together since the two issues got linked). -S. 1895, Lower Health Care Costs Act, support provisions to increase transparency and address anticompetitive practices in the prescription drug market -H.R. 712, VA Medicinal Cannabis Research Act, support addition of epilepsy -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -FDA-2019-N-1428, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, support preservation of meaningful access to cannabis and cannabis-derived products, including CBD tinctures with therapeutic levels of the cannabinoid, and creation of a regulatory framework that ensures that there is consistency in available products, manufacturing, safety, testing, and labeling standards, and increases the availability of important information such as potential side effects and drug interactions so that consumers and practitioners may be better informed -H.R. 2035/S. 995, Lifespan Respite Reauthorization Act, support passage.
-H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage-H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless-H.R. 2093/S. 1028, STATES Act, support passage-H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage- H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage.
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage.
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420/S. 3652 All Dependents Count Act, support passage. -H.R. 6680/S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305/S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage. -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless. -H.R. 2093/S. 1028, STATES Act, support passage. -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage. -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage.
-H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, support funding for agencies like the NIH, FDA and CDC to research, better treat and raise awareness and education about COVID-19, as well as support providing authority to relax restrictions in Medicare for telehealth services and reimbursement. -H.R. 6201, Families First Coronavirus Response Act, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs; funding for agencies to research, better treat and raise awareness and education about COVID-19; expansion of paid sick leave and paid family and medical leave; and free COVD-19 testing regardless of insurance type. -H., CR. 748, CARES Act, support various provisions relevant to people with epilepsy and nonprofit support including access of up to a 90-day supply of medications through the pandemic; funding for agencies to research, better treat and raise awareness and education about COVID-19; prohibiting waivers of the Individuals with Disabilities Education Act (IDEA) and providing funding to ensure that special education needs are met through the pandemic; eligibility of Social Security beneficiaries for Economic Impact Payments and payments for Social Security beneficiaries without filing tax returns; grants to providers of Home and Community-Based Services; and allowing 501(c)(3) organizations and organizations that provide Medicaid services to apply for small business loans. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3, Elijah Cummings Lower Drug Costs Now Act, support specific provisions such as an out-of-pocket cap in Medicare Part D and addition of language to ban the use of QALYs -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -S. 2543, the Prescription Drug Pricing Reduction Act of 2019, support specific provisions such as an out-of-pocket cap in Medicare and improvements to the Medicaid Drug Rebate Program, as well as permanent authorization of the Money Follows the Person program. (Nicole and I did a bunch of these visits together since the two issues got linked). -S. 1895, Lower Health Care Costs Act, support provisions to increase transparency and address anticompetitive practices in the prescription drug market -H.R. 712, VA Medicinal Cannabis Research Act, support addition of epilepsy -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -FDA-2019-N-1428, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, support preservation of meaningful access to cannabis and cannabis-derived products, including CBD tinctures with therapeutic levels of the cannabinoid, and creation of a regulatory framework that ensures that there is consistency in available products, manufacturing, safety, testing, and labeling standards, and increases the availability of important information such as potential side effects and drug interactions so that consumers and practitioners may be better informed -H.R. 2035/S. 995, Lifespan Respite Reauthorization Act, support passage.
-H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage-H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless-H.R. 2093/S. 1028, STATES Act, support passage-H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage- H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.
Elijah E. Cummings Lower Drug Costs Now Act
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, support funding for agencies like the NIH, FDA and CDC to research, better treat and raise awareness and education about COVID-19, as well as support providing authority to relax restrictions in Medicare for telehealth services and reimbursement. -H.R. 6201, Families First Coronavirus Response Act, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs; funding for agencies to research, better treat and raise awareness and education about COVID-19; expansion of paid sick leave and paid family and medical leave; and free COVD-19 testing regardless of insurance type. -H., CR. 748, CARES Act, support various provisions relevant to people with epilepsy and nonprofit support including access of up to a 90-day supply of medications through the pandemic; funding for agencies to research, better treat and raise awareness and education about COVID-19; prohibiting waivers of the Individuals with Disabilities Education Act (IDEA) and providing funding to ensure that special education needs are met through the pandemic; eligibility of Social Security beneficiaries for Economic Impact Payments and payments for Social Security beneficiaries without filing tax returns; grants to providers of Home and Community-Based Services; and allowing 501(c)(3) organizations and organizations that provide Medicaid services to apply for small business loans. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3, Elijah Cummings Lower Drug Costs Now Act, support specific provisions such as an out-of-pocket cap in Medicare Part D and addition of language to ban the use of QALYs -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -S. 2543, the Prescription Drug Pricing Reduction Act of 2019, support specific provisions such as an out-of-pocket cap in Medicare and improvements to the Medicaid Drug Rebate Program, as well as permanent authorization of the Money Follows the Person program. (Nicole and I did a bunch of these visits together since the two issues got linked). -S. 1895, Lower Health Care Costs Act, support provisions to increase transparency and address anticompetitive practices in the prescription drug market -H.R. 712, VA Medicinal Cannabis Research Act, support addition of epilepsy -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -FDA-2019-N-1428, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, support preservation of meaningful access to cannabis and cannabis-derived products, including CBD tinctures with therapeutic levels of the cannabinoid, and creation of a regulatory framework that ensures that there is consistency in available products, manufacturing, safety, testing, and labeling standards, and increases the availability of important information such as potential side effects and drug interactions so that consumers and practitioners may be better informed -H.R. 2035/S. 995, Lifespan Respite Reauthorization Act, support passage.
-H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, support funding for agencies like the NIH, FDA and CDC to research, better treat and raise awareness and education about COVID-19, as well as support providing authority to relax restrictions in Medicare for telehealth services and reimbursement. -H.R. 6201, Families First Coronavirus Response Act, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs; funding for agencies to research, better treat and raise awareness and education about COVID-19; expansion of paid sick leave and paid family and medical leave; and free COVD-19 testing regardless of insurance type. -H., CR. 748, CARES Act, support various provisions relevant to people with epilepsy and nonprofit support including access of up to a 90-day supply of medications through the pandemic; funding for agencies to research, better treat and raise awareness and education about COVID-19; prohibiting waivers of the Individuals with Disabilities Education Act (IDEA) and providing funding to ensure that special education needs are met through the pandemic; eligibility of Social Security beneficiaries for Economic Impact Payments and payments for Social Security beneficiaries without filing tax returns; grants to providers of Home and Community-Based Services; and allowing 501(c)(3) organizations and organizations that provide Medicaid services to apply for small business loans. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3, Elijah Cummings Lower Drug Costs Now Act, support specific provisions such as an out-of-pocket cap in Medicare Part D and addition of language to ban the use of QALYs -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -S. 2543, the Prescription Drug Pricing Reduction Act of 2019, support specific provisions such as an out-of-pocket cap in Medicare and improvements to the Medicaid Drug Rebate Program, as well as permanent authorization of the Money Follows the Person program. (Nicole and I did a bunch of these visits together since the two issues got linked). -S. 1895, Lower Health Care Costs Act, support provisions to increase transparency and address anticompetitive practices in the prescription drug market -H.R. 712, VA Medicinal Cannabis Research Act, support addition of epilepsy -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -FDA-2019-N-1428, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, support preservation of meaningful access to cannabis and cannabis-derived products, including CBD tinctures with therapeutic levels of the cannabinoid, and creation of a regulatory framework that ensures that there is consistency in available products, manufacturing, safety, testing, and labeling standards, and increases the availability of important information such as potential side effects and drug interactions so that consumers and practitioners may be better informed -H.R. 2035/S. 995, Lifespan Respite Reauthorization Act, support passage.
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage.
-H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage-H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless-H.R. 2093/S. 1028, STATES Act, support passage-H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage- H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420/S. 3652 All Dependents Count Act, support passage. -H.R. 6680/S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305/S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage. -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless. -H.R. 2093/S. 1028, STATES Act, support passage. -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage. -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage.
Expanding Cannabis Research and Information Act
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage.
Expanding Cannabis Research and Information Act
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage-H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless-H.R. 2093/S. 1028, STATES Act, support passage-H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage- H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.
Expanding Cannabis Research and Information Act
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420/S. 3652 All Dependents Count Act, support passage. -H.R. 6680/S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305/S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage. -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless. -H.R. 2093/S. 1028, STATES Act, support passage. -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage. -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage.
Expanding Cannabis Research and Information Act
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, support funding for agencies like the NIH, FDA and CDC to research, better treat and raise awareness and education about COVID-19, as well as support providing authority to relax restrictions in Medicare for telehealth services and reimbursement. -H.R. 6201, Families First Coronavirus Response Act, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs; funding for agencies to research, better treat and raise awareness and education about COVID-19; expansion of paid sick leave and paid family and medical leave; and free COVD-19 testing regardless of insurance type. -H., CR. 748, CARES Act, support various provisions relevant to people with epilepsy and nonprofit support including access of up to a 90-day supply of medications through the pandemic; funding for agencies to research, better treat and raise awareness and education about COVID-19; prohibiting waivers of the Individuals with Disabilities Education Act (IDEA) and providing funding to ensure that special education needs are met through the pandemic; eligibility of Social Security beneficiaries for Economic Impact Payments and payments for Social Security beneficiaries without filing tax returns; grants to providers of Home and Community-Based Services; and allowing 501(c)(3) organizations and organizations that provide Medicaid services to apply for small business loans. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3, Elijah Cummings Lower Drug Costs Now Act, support specific provisions such as an out-of-pocket cap in Medicare Part D and addition of language to ban the use of QALYs -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -S. 2543, the Prescription Drug Pricing Reduction Act of 2019, support specific provisions such as an out-of-pocket cap in Medicare and improvements to the Medicaid Drug Rebate Program, as well as permanent authorization of the Money Follows the Person program. (Nicole and I did a bunch of these visits together since the two issues got linked). -S. 1895, Lower Health Care Costs Act, support provisions to increase transparency and address anticompetitive practices in the prescription drug market -H.R. 712, VA Medicinal Cannabis Research Act, support addition of epilepsy -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -FDA-2019-N-1428, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, support preservation of meaningful access to cannabis and cannabis-derived products, including CBD tinctures with therapeutic levels of the cannabinoid, and creation of a regulatory framework that ensures that there is consistency in available products, manufacturing, safety, testing, and labeling standards, and increases the availability of important information such as potential side effects and drug interactions so that consumers and practitioners may be better informed -H.R. 2035/S. 995, Lifespan Respite Reauthorization Act, support passage.
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420/S. 3652 All Dependents Count Act, support passage. -H.R. 6680/S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305/S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage. -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless. -H.R. 2093/S. 1028, STATES Act, support passage. -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage. -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage.
-H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage-H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless-H.R. 2093/S. 1028, STATES Act, support passage-H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage- H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage.
-H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, support funding for agencies like the NIH, FDA and CDC to research, better treat and raise awareness and education about COVID-19, as well as support providing authority to relax restrictions in Medicare for telehealth services and reimbursement. -H.R. 6201, Families First Coronavirus Response Act, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs; funding for agencies to research, better treat and raise awareness and education about COVID-19; expansion of paid sick leave and paid family and medical leave; and free COVD-19 testing regardless of insurance type. -H., CR. 748, CARES Act, support various provisions relevant to people with epilepsy and nonprofit support including access of up to a 90-day supply of medications through the pandemic; funding for agencies to research, better treat and raise awareness and education about COVID-19; prohibiting waivers of the Individuals with Disabilities Education Act (IDEA) and providing funding to ensure that special education needs are met through the pandemic; eligibility of Social Security beneficiaries for Economic Impact Payments and payments for Social Security beneficiaries without filing tax returns; grants to providers of Home and Community-Based Services; and allowing 501(c)(3) organizations and organizations that provide Medicaid services to apply for small business loans. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3, Elijah Cummings Lower Drug Costs Now Act, support specific provisions such as an out-of-pocket cap in Medicare Part D and addition of language to ban the use of QALYs -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -S. 2543, the Prescription Drug Pricing Reduction Act of 2019, support specific provisions such as an out-of-pocket cap in Medicare and improvements to the Medicaid Drug Rebate Program, as well as permanent authorization of the Money Follows the Person program. (Nicole and I did a bunch of these visits together since the two issues got linked). -S. 1895, Lower Health Care Costs Act, support provisions to increase transparency and address anticompetitive practices in the prescription drug market -H.R. 712, VA Medicinal Cannabis Research Act, support addition of epilepsy -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -FDA-2019-N-1428, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, support preservation of meaningful access to cannabis and cannabis-derived products, including CBD tinctures with therapeutic levels of the cannabinoid, and creation of a regulatory framework that ensures that there is consistency in available products, manufacturing, safety, testing, and labeling standards, and increases the availability of important information such as potential side effects and drug interactions so that consumers and practitioners may be better informed -H.R. 2035/S. 995, Lifespan Respite Reauthorization Act, support passage.
Consumer Protections Against Surprise Medical Bills Act of 2020
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage.
Consumer Protections Against Surprise Medical Bills Act of 2020
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420/S. 3652 All Dependents Count Act, support passage. -H.R. 6680/S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305/S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage. -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless. -H.R. 2093/S. 1028, STATES Act, support passage. -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage. -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage.
Consumer Protections Against Surprise Medical Bills Act of 2020
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, support funding for agencies like the NIH, FDA and CDC to research, better treat and raise awareness and education about COVID-19, as well as support providing authority to relax restrictions in Medicare for telehealth services and reimbursement. -H.R. 6201, Families First Coronavirus Response Act, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs; funding for agencies to research, better treat and raise awareness and education about COVID-19; expansion of paid sick leave and paid family and medical leave; and free COVD-19 testing regardless of insurance type. -H., CR. 748, CARES Act, support various provisions relevant to people with epilepsy and nonprofit support including access of up to a 90-day supply of medications through the pandemic; funding for agencies to research, better treat and raise awareness and education about COVID-19; prohibiting waivers of the Individuals with Disabilities Education Act (IDEA) and providing funding to ensure that special education needs are met through the pandemic; eligibility of Social Security beneficiaries for Economic Impact Payments and payments for Social Security beneficiaries without filing tax returns; grants to providers of Home and Community-Based Services; and allowing 501(c)(3) organizations and organizations that provide Medicaid services to apply for small business loans. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3, Elijah Cummings Lower Drug Costs Now Act, support specific provisions such as an out-of-pocket cap in Medicare Part D and addition of language to ban the use of QALYs -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -S. 2543, the Prescription Drug Pricing Reduction Act of 2019, support specific provisions such as an out-of-pocket cap in Medicare and improvements to the Medicaid Drug Rebate Program, as well as permanent authorization of the Money Follows the Person program. (Nicole and I did a bunch of these visits together since the two issues got linked). -S. 1895, Lower Health Care Costs Act, support provisions to increase transparency and address anticompetitive practices in the prescription drug market -H.R. 712, VA Medicinal Cannabis Research Act, support addition of epilepsy -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -FDA-2019-N-1428, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, support preservation of meaningful access to cannabis and cannabis-derived products, including CBD tinctures with therapeutic levels of the cannabinoid, and creation of a regulatory framework that ensures that there is consistency in available products, manufacturing, safety, testing, and labeling standards, and increases the availability of important information such as potential side effects and drug interactions so that consumers and practitioners may be better informed -H.R. 2035/S. 995, Lifespan Respite Reauthorization Act, support passage.
Consumer Protections Against Surprise Medical Bills Act of 2020
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage-H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless-H.R. 2093/S. 1028, STATES Act, support passage-H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage- H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, support funding for agencies like the NIH, FDA and CDC to research, better treat and raise awareness and education about COVID-19, as well as support providing authority to relax restrictions in Medicare for telehealth services and reimbursement. -H.R. 6201, Families First Coronavirus Response Act, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs; funding for agencies to research, better treat and raise awareness and education about COVID-19; expansion of paid sick leave and paid family and medical leave; and free COVD-19 testing regardless of insurance type. -H., CR. 748, CARES Act, support various provisions relevant to people with epilepsy and nonprofit support including access of up to a 90-day supply of medications through the pandemic; funding for agencies to research, better treat and raise awareness and education about COVID-19; prohibiting waivers of the Individuals with Disabilities Education Act (IDEA) and providing funding to ensure that special education needs are met through the pandemic; eligibility of Social Security beneficiaries for Economic Impact Payments and payments for Social Security beneficiaries without filing tax returns; grants to providers of Home and Community-Based Services; and allowing 501(c)(3) organizations and organizations that provide Medicaid services to apply for small business loans. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3, Elijah Cummings Lower Drug Costs Now Act, support specific provisions such as an out-of-pocket cap in Medicare Part D and addition of language to ban the use of QALYs -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -S. 2543, the Prescription Drug Pricing Reduction Act of 2019, support specific provisions such as an out-of-pocket cap in Medicare and improvements to the Medicaid Drug Rebate Program, as well as permanent authorization of the Money Follows the Person program. (Nicole and I did a bunch of these visits together since the two issues got linked). -S. 1895, Lower Health Care Costs Act, support provisions to increase transparency and address anticompetitive practices in the prescription drug market -H.R. 712, VA Medicinal Cannabis Research Act, support addition of epilepsy -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -FDA-2019-N-1428, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, support preservation of meaningful access to cannabis and cannabis-derived products, including CBD tinctures with therapeutic levels of the cannabinoid, and creation of a regulatory framework that ensures that there is consistency in available products, manufacturing, safety, testing, and labeling standards, and increases the availability of important information such as potential side effects and drug interactions so that consumers and practitioners may be better informed -H.R. 2035/S. 995, Lifespan Respite Reauthorization Act, support passage.
Families First Coronavirus Response Act
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, support funding for agencies like the NIH, FDA and CDC to research, better treat and raise awareness and education about COVID-19, as well as support providing authority to relax restrictions in Medicare for telehealth services and reimbursement. -H.R. 6201, Families First Coronavirus Response Act, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs; funding for agencies to research, better treat and raise awareness and education about COVID-19; expansion of paid sick leave and paid family and medical leave; and free COVD-19 testing regardless of insurance type. -H., CR. 748, CARES Act, support various provisions relevant to people with epilepsy and nonprofit support including access of up to a 90-day supply of medications through the pandemic; funding for agencies to research, better treat and raise awareness and education about COVID-19; prohibiting waivers of the Individuals with Disabilities Education Act (IDEA) and providing funding to ensure that special education needs are met through the pandemic; eligibility of Social Security beneficiaries for Economic Impact Payments and payments for Social Security beneficiaries without filing tax returns; grants to providers of Home and Community-Based Services; and allowing 501(c)(3) organizations and organizations that provide Medicaid services to apply for small business loans. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3, Elijah Cummings Lower Drug Costs Now Act, support specific provisions such as an out-of-pocket cap in Medicare Part D and addition of language to ban the use of QALYs -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -S. 2543, the Prescription Drug Pricing Reduction Act of 2019, support specific provisions such as an out-of-pocket cap in Medicare and improvements to the Medicaid Drug Rebate Program, as well as permanent authorization of the Money Follows the Person program. (Nicole and I did a bunch of these visits together since the two issues got linked). -S. 1895, Lower Health Care Costs Act, support provisions to increase transparency and address anticompetitive practices in the prescription drug market -H.R. 712, VA Medicinal Cannabis Research Act, support addition of epilepsy -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -FDA-2019-N-1428, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, support preservation of meaningful access to cannabis and cannabis-derived products, including CBD tinctures with therapeutic levels of the cannabinoid, and creation of a regulatory framework that ensures that there is consistency in available products, manufacturing, safety, testing, and labeling standards, and increases the availability of important information such as potential side effects and drug interactions so that consumers and practitioners may be better informed -H.R. 2035/S. 995, Lifespan Respite Reauthorization Act, support passage.
Coronavirus Relief for Seniors and People with Disabilities Act of 2020
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage.
Coronavirus Relief for Seniors and People with Disabilities Act of 2020
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420/S. 3652 All Dependents Count Act, support passage. -H.R. 6680/S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305/S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage. -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless. -H.R. 2093/S. 1028, STATES Act, support passage. -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage. -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage.
Coronavirus Relief for Seniors and People with Disabilities Act of 2020
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage-H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless-H.R. 2093/S. 1028, STATES Act, support passage-H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage- H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.
-H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage-H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless-H.R. 2093/S. 1028, STATES Act, support passage-H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage- H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420/S. 3652 All Dependents Count Act, support passage. -H.R. 6680/S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305/S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage. -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless. -H.R. 2093/S. 1028, STATES Act, support passage. -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage. -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage.
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage.
Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage-H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless-H.R. 2093/S. 1028, STATES Act, support passage-H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage- H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.
Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage.
Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420/S. 3652 All Dependents Count Act, support passage. -H.R. 6680/S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305/S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage. -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless. -H.R. 2093/S. 1028, STATES Act, support passage. -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage. -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage.
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420/S. 3652 All Dependents Count Act, support passage. -H.R. 6680/S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305/S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage. -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless. -H.R. 2093/S. 1028, STATES Act, support passage. -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage. -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage.
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage.
VA Medicinal Cannabis Research Act of 2019
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, support funding for agencies like the NIH, FDA and CDC to research, better treat and raise awareness and education about COVID-19, as well as support providing authority to relax restrictions in Medicare for telehealth services and reimbursement. -H.R. 6201, Families First Coronavirus Response Act, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs; funding for agencies to research, better treat and raise awareness and education about COVID-19; expansion of paid sick leave and paid family and medical leave; and free COVD-19 testing regardless of insurance type. -H., CR. 748, CARES Act, support various provisions relevant to people with epilepsy and nonprofit support including access of up to a 90-day supply of medications through the pandemic; funding for agencies to research, better treat and raise awareness and education about COVID-19; prohibiting waivers of the Individuals with Disabilities Education Act (IDEA) and providing funding to ensure that special education needs are met through the pandemic; eligibility of Social Security beneficiaries for Economic Impact Payments and payments for Social Security beneficiaries without filing tax returns; grants to providers of Home and Community-Based Services; and allowing 501(c)(3) organizations and organizations that provide Medicaid services to apply for small business loans. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3, Elijah Cummings Lower Drug Costs Now Act, support specific provisions such as an out-of-pocket cap in Medicare Part D and addition of language to ban the use of QALYs -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -S. 2543, the Prescription Drug Pricing Reduction Act of 2019, support specific provisions such as an out-of-pocket cap in Medicare and improvements to the Medicaid Drug Rebate Program, as well as permanent authorization of the Money Follows the Person program. (Nicole and I did a bunch of these visits together since the two issues got linked). -S. 1895, Lower Health Care Costs Act, support provisions to increase transparency and address anticompetitive practices in the prescription drug market -H.R. 712, VA Medicinal Cannabis Research Act, support addition of epilepsy -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -FDA-2019-N-1428, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, support preservation of meaningful access to cannabis and cannabis-derived products, including CBD tinctures with therapeutic levels of the cannabinoid, and creation of a regulatory framework that ensures that there is consistency in available products, manufacturing, safety, testing, and labeling standards, and increases the availability of important information such as potential side effects and drug interactions so that consumers and practitioners may be better informed -H.R. 2035/S. 995, Lifespan Respite Reauthorization Act, support passage.
Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2021, and for other purposes.
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 7614, Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2021, support funding for epilepsy programs and research including $11.5 million for the CDCs Epilepsy program, $44.7 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System and $10 million for Lifespan Respite Care Program. -H.R. 7610, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2021, support robust funding for the Food & Drug Administration. -H.R. 7617, Defense Appropriations Act, 2021, support robust funding for the Congressionally Directed Medical Research Programs.
Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2021, and for other purposes.
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 7614, Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2021, support funding for epilepsy programs and research including $11.5 million for the CDCs Epilepsy program, $44.7 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System, and $10 million for Lifespan Respite Care Program -H.R. 7610, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2021, support robust funding for the Food & Drug Administration. -H.R. 7617, Defense Appropriations Act, 2021, support robust funding for the Congressionally Directed Medical Research Programs. -H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021, support passage.
Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2021, and for other purposes.
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 7614, Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2021, support funding for epilepsy programs and research including $11.5 million for the CDCs Epilepsy program, $44.7 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System, and $10 million for Lifespan Respite Care Program -H.R. 7610, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2021, support robust funding for the Food & Drug Administration. -H.R. 7617, Defense Appropriations Act, 2021, support robust funding for the Congressionally Directed Medical Research Programs. -H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 7614, Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2021, support funding for epilepsy programs and research including $11.5 million for the CDCs Epilepsy program, $44.7 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System, and $10 million for Lifespan Respite Care Program -H.R. 7610, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2021, support robust funding for the Food & Drug Administration. -H.R. 7617, Defense Appropriations Act, 2021, support robust funding for the Congressionally Directed Medical Research Programs. -H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021, support passage.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 7614, Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2021, support funding for epilepsy programs and research including $11.5 million for the CDCs Epilepsy program, $44.7 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System, and $10 million for Lifespan Respite Care Program -H.R. 7610, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2021, support robust funding for the Food & Drug Administration. -H.R. 7617, Defense Appropriations Act, 2021, support robust funding for the Congressionally Directed Medical Research Programs. -H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 7614, Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2021, support funding for epilepsy programs and research including $11.5 million for the CDCs Epilepsy program, $44.7 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System and $10 million for Lifespan Respite Care Program. -H.R. 7610, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2021, support robust funding for the Food & Drug Administration. -H.R. 7617, Defense Appropriations Act, 2021, support robust funding for the Congressionally Directed Medical Research Programs.
Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 7614, Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2021, support funding for epilepsy programs and research including $11.5 million for the CDCs Epilepsy program, $44.7 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System, and $10 million for Lifespan Respite Care Program -H.R. 7610, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2021, support robust funding for the Food & Drug Administration. -H.R. 7617, Defense Appropriations Act, 2021, support robust funding for the Congressionally Directed Medical Research Programs. -H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.
Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 7614, Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2021, support funding for epilepsy programs and research including $11.5 million for the CDCs Epilepsy program, $44.7 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System, and $10 million for Lifespan Respite Care Program -H.R. 7610, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2021, support robust funding for the Food & Drug Administration. -H.R. 7617, Defense Appropriations Act, 2021, support robust funding for the Congressionally Directed Medical Research Programs. -H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021, support passage.
Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 7614, Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2021, support funding for epilepsy programs and research including $11.5 million for the CDCs Epilepsy program, $44.7 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System and $10 million for Lifespan Respite Care Program. -H.R. 7610, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2021, support robust funding for the Food & Drug Administration. -H.R. 7617, Defense Appropriations Act, 2021, support robust funding for the Congressionally Directed Medical Research Programs.
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage.
-H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage-H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless-H.R. 2093/S. 1028, STATES Act, support passage-H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage- H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.
-H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, support funding for agencies like the NIH, FDA and CDC to research, better treat and raise awareness and education about COVID-19, as well as support providing authority to relax restrictions in Medicare for telehealth services and reimbursement. -H.R. 6201, Families First Coronavirus Response Act, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs; funding for agencies to research, better treat and raise awareness and education about COVID-19; expansion of paid sick leave and paid family and medical leave; and free COVD-19 testing regardless of insurance type. -H., CR. 748, CARES Act, support various provisions relevant to people with epilepsy and nonprofit support including access of up to a 90-day supply of medications through the pandemic; funding for agencies to research, better treat and raise awareness and education about COVID-19; prohibiting waivers of the Individuals with Disabilities Education Act (IDEA) and providing funding to ensure that special education needs are met through the pandemic; eligibility of Social Security beneficiaries for Economic Impact Payments and payments for Social Security beneficiaries without filing tax returns; grants to providers of Home and Community-Based Services; and allowing 501(c)(3) organizations and organizations that provide Medicaid services to apply for small business loans. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3, Elijah Cummings Lower Drug Costs Now Act, support specific provisions such as an out-of-pocket cap in Medicare Part D and addition of language to ban the use of QALYs -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -S. 2543, the Prescription Drug Pricing Reduction Act of 2019, support specific provisions such as an out-of-pocket cap in Medicare and improvements to the Medicaid Drug Rebate Program, as well as permanent authorization of the Money Follows the Person program. (Nicole and I did a bunch of these visits together since the two issues got linked). -S. 1895, Lower Health Care Costs Act, support provisions to increase transparency and address anticompetitive practices in the prescription drug market -H.R. 712, VA Medicinal Cannabis Research Act, support addition of epilepsy -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -FDA-2019-N-1428, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, support preservation of meaningful access to cannabis and cannabis-derived products, including CBD tinctures with therapeutic levels of the cannabinoid, and creation of a regulatory framework that ensures that there is consistency in available products, manufacturing, safety, testing, and labeling standards, and increases the availability of important information such as potential side effects and drug interactions so that consumers and practitioners may be better informed -H.R. 2035/S. 995, Lifespan Respite Reauthorization Act, support passage.
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420/S. 3652 All Dependents Count Act, support passage. -H.R. 6680/S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305/S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage. -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless. -H.R. 2093/S. 1028, STATES Act, support passage. -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage. -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage.
STOP Surprise Medical Bills Act of 2019
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage-H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless-H.R. 2093/S. 1028, STATES Act, support passage-H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage- H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.
STOP Surprise Medical Bills Act of 2019
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420/S. 3652 All Dependents Count Act, support passage. -H.R. 6680/S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305/S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage. -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless. -H.R. 2093/S. 1028, STATES Act, support passage. -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage. -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage.
STOP Surprise Medical Bills Act of 2019
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, support funding for agencies like the NIH, FDA and CDC to research, better treat and raise awareness and education about COVID-19, as well as support providing authority to relax restrictions in Medicare for telehealth services and reimbursement. -H.R. 6201, Families First Coronavirus Response Act, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs; funding for agencies to research, better treat and raise awareness and education about COVID-19; expansion of paid sick leave and paid family and medical leave; and free COVD-19 testing regardless of insurance type. -H., CR. 748, CARES Act, support various provisions relevant to people with epilepsy and nonprofit support including access of up to a 90-day supply of medications through the pandemic; funding for agencies to research, better treat and raise awareness and education about COVID-19; prohibiting waivers of the Individuals with Disabilities Education Act (IDEA) and providing funding to ensure that special education needs are met through the pandemic; eligibility of Social Security beneficiaries for Economic Impact Payments and payments for Social Security beneficiaries without filing tax returns; grants to providers of Home and Community-Based Services; and allowing 501(c)(3) organizations and organizations that provide Medicaid services to apply for small business loans. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3, Elijah Cummings Lower Drug Costs Now Act, support specific provisions such as an out-of-pocket cap in Medicare Part D and addition of language to ban the use of QALYs -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -S. 2543, the Prescription Drug Pricing Reduction Act of 2019, support specific provisions such as an out-of-pocket cap in Medicare and improvements to the Medicaid Drug Rebate Program, as well as permanent authorization of the Money Follows the Person program. (Nicole and I did a bunch of these visits together since the two issues got linked). -S. 1895, Lower Health Care Costs Act, support provisions to increase transparency and address anticompetitive practices in the prescription drug market -H.R. 712, VA Medicinal Cannabis Research Act, support addition of epilepsy -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -FDA-2019-N-1428, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, support preservation of meaningful access to cannabis and cannabis-derived products, including CBD tinctures with therapeutic levels of the cannabinoid, and creation of a regulatory framework that ensures that there is consistency in available products, manufacturing, safety, testing, and labeling standards, and increases the availability of important information such as potential side effects and drug interactions so that consumers and practitioners may be better informed -H.R. 2035/S. 995, Lifespan Respite Reauthorization Act, support passage.
STOP Surprise Medical Bills Act of 2019
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage.
-H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, support funding for agencies like the NIH, FDA and CDC to research, better treat and raise awareness and education about COVID-19, as well as support providing authority to relax restrictions in Medicare for telehealth services and reimbursement. -H.R. 6201, Families First Coronavirus Response Act, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs; funding for agencies to research, better treat and raise awareness and education about COVID-19; expansion of paid sick leave and paid family and medical leave; and free COVD-19 testing regardless of insurance type. -H., CR. 748, CARES Act, support various provisions relevant to people with epilepsy and nonprofit support including access of up to a 90-day supply of medications through the pandemic; funding for agencies to research, better treat and raise awareness and education about COVID-19; prohibiting waivers of the Individuals with Disabilities Education Act (IDEA) and providing funding to ensure that special education needs are met through the pandemic; eligibility of Social Security beneficiaries for Economic Impact Payments and payments for Social Security beneficiaries without filing tax returns; grants to providers of Home and Community-Based Services; and allowing 501(c)(3) organizations and organizations that provide Medicaid services to apply for small business loans. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3, Elijah Cummings Lower Drug Costs Now Act, support specific provisions such as an out-of-pocket cap in Medicare Part D and addition of language to ban the use of QALYs -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -S. 2543, the Prescription Drug Pricing Reduction Act of 2019, support specific provisions such as an out-of-pocket cap in Medicare and improvements to the Medicaid Drug Rebate Program, as well as permanent authorization of the Money Follows the Person program. (Nicole and I did a bunch of these visits together since the two issues got linked). -S. 1895, Lower Health Care Costs Act, support provisions to increase transparency and address anticompetitive practices in the prescription drug market -H.R. 712, VA Medicinal Cannabis Research Act, support addition of epilepsy -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -FDA-2019-N-1428, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, support preservation of meaningful access to cannabis and cannabis-derived products, including CBD tinctures with therapeutic levels of the cannabinoid, and creation of a regulatory framework that ensures that there is consistency in available products, manufacturing, safety, testing, and labeling standards, and increases the availability of important information such as potential side effects and drug interactions so that consumers and practitioners may be better informed -H.R. 2035/S. 995, Lifespan Respite Reauthorization Act, support passage.
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420/S. 3652 All Dependents Count Act, support passage. -H.R. 6680/S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305/S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage. -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless. -H.R. 2093/S. 1028, STATES Act, support passage. -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage. -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage.
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage.
-H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage-H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless-H.R. 2093/S. 1028, STATES Act, support passage-H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage- H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.
Expanding Cannabis Research and Information Act
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, support funding for agencies like the NIH, FDA and CDC to research, better treat and raise awareness and education about COVID-19, as well as support providing authority to relax restrictions in Medicare for telehealth services and reimbursement. -H.R. 6201, Families First Coronavirus Response Act, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs; funding for agencies to research, better treat and raise awareness and education about COVID-19; expansion of paid sick leave and paid family and medical leave; and free COVD-19 testing regardless of insurance type. -H., CR. 748, CARES Act, support various provisions relevant to people with epilepsy and nonprofit support including access of up to a 90-day supply of medications through the pandemic; funding for agencies to research, better treat and raise awareness and education about COVID-19; prohibiting waivers of the Individuals with Disabilities Education Act (IDEA) and providing funding to ensure that special education needs are met through the pandemic; eligibility of Social Security beneficiaries for Economic Impact Payments and payments for Social Security beneficiaries without filing tax returns; grants to providers of Home and Community-Based Services; and allowing 501(c)(3) organizations and organizations that provide Medicaid services to apply for small business loans. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3, Elijah Cummings Lower Drug Costs Now Act, support specific provisions such as an out-of-pocket cap in Medicare Part D and addition of language to ban the use of QALYs -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -S. 2543, the Prescription Drug Pricing Reduction Act of 2019, support specific provisions such as an out-of-pocket cap in Medicare and improvements to the Medicaid Drug Rebate Program, as well as permanent authorization of the Money Follows the Person program. (Nicole and I did a bunch of these visits together since the two issues got linked). -S. 1895, Lower Health Care Costs Act, support provisions to increase transparency and address anticompetitive practices in the prescription drug market -H.R. 712, VA Medicinal Cannabis Research Act, support addition of epilepsy -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -FDA-2019-N-1428, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, support preservation of meaningful access to cannabis and cannabis-derived products, including CBD tinctures with therapeutic levels of the cannabinoid, and creation of a regulatory framework that ensures that there is consistency in available products, manufacturing, safety, testing, and labeling standards, and increases the availability of important information such as potential side effects and drug interactions so that consumers and practitioners may be better informed -H.R. 2035/S. 995, Lifespan Respite Reauthorization Act, support passage.
Expanding Cannabis Research and Information Act
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420/S. 3652 All Dependents Count Act, support passage. -H.R. 6680/S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305/S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage. -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless. -H.R. 2093/S. 1028, STATES Act, support passage. -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage. -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage.
Expanding Cannabis Research and Information Act
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage.
Expanding Cannabis Research and Information Act
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage-H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless-H.R. 2093/S. 1028, STATES Act, support passage-H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage- H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.
Prescription Drug Pricing Reduction Act of 2019
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, support funding for agencies like the NIH, FDA and CDC to research, better treat and raise awareness and education about COVID-19, as well as support providing authority to relax restrictions in Medicare for telehealth services and reimbursement. -H.R. 6201, Families First Coronavirus Response Act, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs; funding for agencies to research, better treat and raise awareness and education about COVID-19; expansion of paid sick leave and paid family and medical leave; and free COVD-19 testing regardless of insurance type. -H., CR. 748, CARES Act, support various provisions relevant to people with epilepsy and nonprofit support including access of up to a 90-day supply of medications through the pandemic; funding for agencies to research, better treat and raise awareness and education about COVID-19; prohibiting waivers of the Individuals with Disabilities Education Act (IDEA) and providing funding to ensure that special education needs are met through the pandemic; eligibility of Social Security beneficiaries for Economic Impact Payments and payments for Social Security beneficiaries without filing tax returns; grants to providers of Home and Community-Based Services; and allowing 501(c)(3) organizations and organizations that provide Medicaid services to apply for small business loans. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3, Elijah Cummings Lower Drug Costs Now Act, support specific provisions such as an out-of-pocket cap in Medicare Part D and addition of language to ban the use of QALYs -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -S. 2543, the Prescription Drug Pricing Reduction Act of 2019, support specific provisions such as an out-of-pocket cap in Medicare and improvements to the Medicaid Drug Rebate Program, as well as permanent authorization of the Money Follows the Person program. (Nicole and I did a bunch of these visits together since the two issues got linked). -S. 1895, Lower Health Care Costs Act, support provisions to increase transparency and address anticompetitive practices in the prescription drug market -H.R. 712, VA Medicinal Cannabis Research Act, support addition of epilepsy -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -FDA-2019-N-1428, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, support preservation of meaningful access to cannabis and cannabis-derived products, including CBD tinctures with therapeutic levels of the cannabinoid, and creation of a regulatory framework that ensures that there is consistency in available products, manufacturing, safety, testing, and labeling standards, and increases the availability of important information such as potential side effects and drug interactions so that consumers and practitioners may be better informed -H.R. 2035/S. 995, Lifespan Respite Reauthorization Act, support passage.
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420/S. 3652 All Dependents Count Act, support passage. -H.R. 6680/S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305/S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage. -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless. -H.R. 2093/S. 1028, STATES Act, support passage. -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage. -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage.
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage.
-H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage-H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless-H.R. 2093/S. 1028, STATES Act, support passage-H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage- H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.
-H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, support funding for agencies like the NIH, FDA and CDC to research, better treat and raise awareness and education about COVID-19, as well as support providing authority to relax restrictions in Medicare for telehealth services and reimbursement. -H.R. 6201, Families First Coronavirus Response Act, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs; funding for agencies to research, better treat and raise awareness and education about COVID-19; expansion of paid sick leave and paid family and medical leave; and free COVD-19 testing regardless of insurance type. -H., CR. 748, CARES Act, support various provisions relevant to people with epilepsy and nonprofit support including access of up to a 90-day supply of medications through the pandemic; funding for agencies to research, better treat and raise awareness and education about COVID-19; prohibiting waivers of the Individuals with Disabilities Education Act (IDEA) and providing funding to ensure that special education needs are met through the pandemic; eligibility of Social Security beneficiaries for Economic Impact Payments and payments for Social Security beneficiaries without filing tax returns; grants to providers of Home and Community-Based Services; and allowing 501(c)(3) organizations and organizations that provide Medicaid services to apply for small business loans. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3, Elijah Cummings Lower Drug Costs Now Act, support specific provisions such as an out-of-pocket cap in Medicare Part D and addition of language to ban the use of QALYs -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -S. 2543, the Prescription Drug Pricing Reduction Act of 2019, support specific provisions such as an out-of-pocket cap in Medicare and improvements to the Medicaid Drug Rebate Program, as well as permanent authorization of the Money Follows the Person program. (Nicole and I did a bunch of these visits together since the two issues got linked). -S. 1895, Lower Health Care Costs Act, support provisions to increase transparency and address anticompetitive practices in the prescription drug market -H.R. 712, VA Medicinal Cannabis Research Act, support addition of epilepsy -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -FDA-2019-N-1428, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, support preservation of meaningful access to cannabis and cannabis-derived products, including CBD tinctures with therapeutic levels of the cannabinoid, and creation of a regulatory framework that ensures that there is consistency in available products, manufacturing, safety, testing, and labeling standards, and increases the availability of important information such as potential side effects and drug interactions so that consumers and practitioners may be better informed -H.R. 2035/S. 995, Lifespan Respite Reauthorization Act, support passage.
Coronavirus Relief for Seniors and People with Disabilities Act of 2020
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage-H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless-H.R. 2093/S. 1028, STATES Act, support passage-H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage- H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.
Coronavirus Relief for Seniors and People with Disabilities Act of 2020
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage.
Coronavirus Relief for Seniors and People with Disabilities Act of 2020
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420/S. 3652 All Dependents Count Act, support passage. -H.R. 6680/S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305/S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage. -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless. -H.R. 2093/S. 1028, STATES Act, support passage. -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage. -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage.
Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act
Client: EPILEPSY FOUNDATION · Firm: EPILEPSY FOUNDATION
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420/S. 3652 All Dependents Count Act, support passage. -H.R. 6680/S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305/S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage. -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless. -H.R. 2093/S. 1028, STATES Act, support passage. -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage. -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage.
-Build Back Better Act, support $400 billion for Medicaid home- and community-based services; addressing affordability of health insurance premiums; creating an out-of-pocket cap in Medicare Part D with smoothing mechanism; bar use of discriminatory quality-adjusted life year (QALY) in prescription drug legislation; preserving the Orphan Drug Tax Credit; creating a comprehensive paid family and medical leave program; adding vision, dental, and hearing coverage to Medicare; raising asset limits and other improvements to supplemental security income; expanding low-income subsidies in Medicare. -Ensure access to medications in emergencies in pandemic preparedness legislation. -HCBS Access Act, support development of legislation that would make Medicaid HCBS mandatory, end the waiting list, enhance HCBS services, and provide proper support to the direct support workforce. -S. 464/H.R. 2163, Safe Step Act, support passage. -S. 253, Marihuana Research Expansion Act and Medical Marijuana Research Act, support passage. -Identify and make recommendations on improvements to federal law for access to medical cannabis and medical cannabis products. -Support creation of a Neuroscience Center of Excellence at the FDA.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EPILEPSY FOUNDATION via EPILEPSY FOUNDATION
2021 · second_quarter · Q2
-Address affordability of health insurance premiums, out-of-pocket costs, support and expand Medicaid coverage and limit inadequate short-term limited duration and other non-compliant plans. -Create an out-of-pocket cap in Medicare Part D with smoothing mechanism, bar use of discriminatory quality-adjusted life year (QALY) in prescription drug legislation; improve Medicare coverage for low income beneficiaries; add vision, dental, and hearing coverage to Medicare -Include provisions ensuring access to medications in emergencies in pandemic preparedness legislation -S. 2210, Better Care Better Jobs Act, support passage to enhance funding for and expand access to Medicaid home- and community-based services (HCBS) and permanently reauthorize Money Follows the Person -HCBS Access Act, support development of legislation that would make Medicaid HCBS mandatory, end the waiting list, enhance HCBS services, and provide proper support to the direct support workforce. -Provide a $400 billion investment in Medicaid home-and community-based services (HCBS) as outlined in the Build Back Better Agenda -S. 464/H.R. 2163, Safe Step Act, support passage -S. 253, Marihuana Research Expansion Act and Medical Marijuana Research Act, support passage -Identify and make recommendations on improvements to federal law for access to medical cannabis and medical cannabis products.
-H.R. 4502, Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2022, support funding for epilepsy programs and research including $13 million for the CDCs Epilepsy program, $46.1 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System. -H.R.4355, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022, support $13 million for the VA Epilepsy Centers of Excellence. -H.R. 4356, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2022, support robust funding for the Food & Drug Administration. -H.R. 4432, Defense Appropriations Act, 2022, support robust funding for the Congressionally Directed Medical Research Programs.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EPILEPSY FOUNDATION via EPILEPSY FOUNDATION
2021 · first_quarter · Q1
-Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2022, support funding for epilepsy programs and research including $13 million for the CDCs Epilepsy program, $46.1 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System. -Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022, support $13 million for the VA Epilepsy Centers of Excellence. -Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2022, support robust funding for the Food & Drug Administration. -Defense Appropriations Act, 2022, support robust funding for the Congressionally Directed Medical Research Programs.
-H.R. 1319, American Rescue Plan, support dedicated funding for Medicaid home- and community-based services; including adult dependents in Economic Impact Payments; extension of emergency paid leave tax credits; and provisions to improve affordability of health coverage including subsidizing premium costs for those on COBA and increasing subsidies to purchase coverage through the Affordable Care Act. -Oppose weakening of Medicares Six Protected Classes contained in Calendar Year 2022 Request for Applications for the Part D Payment Modernization Model. -S. 464, Safe Step Act, support passage. -S. 253, Marihuana Research Expansion Act and Medical Marijuana Research Act, support passage.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EPILEPSY FOUNDATION via EPILEPSY FOUNDATION
2020 · fourth_quarter · Q4
-H.R. 7614, Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2021, support funding for epilepsy programs and research including $11.5 million for the CDCs Epilepsy program, $44.7 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System, and $10 million for Lifespan Respite Care Program -H.R. 7610, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2021, support robust funding for the Food & Drug Administration. -H.R. 7617, Defense Appropriations Act, 2021, support robust funding for the Congressionally Directed Medical Research Programs. -H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.
-H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage-H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless-H.R. 2093/S. 1028, STATES Act, support passage-H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage- H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EPILEPSY FOUNDATION via EPILEPSY FOUNDATION
2020 · third_quarter · Q3
-H.R. 7614, Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2021, support funding for epilepsy programs and research including $11.5 million for the CDCs Epilepsy program, $44.7 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System, and $10 million for Lifespan Respite Care Program -H.R. 7610, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2021, support robust funding for the Food & Drug Administration. -H.R. 7617, Defense Appropriations Act, 2021, support robust funding for the Congressionally Directed Medical Research Programs. -H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021, support passage.
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EPILEPSY FOUNDATION via EPILEPSY FOUNDATION
2020 · second_quarter · Q2
-H.R. 6800, HEROES Act and Senate-led COVID-19 package, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs and targeted support for Medicaid home- and community-based services; Medicaid maintenance of effort provisions; nationwide reopening of Marketplace special enrollment period; expansion of paid sick leave and paid family and medical leave; institute guardrails and protections around step therapy and other utilization management; making permanent flexibilities to allow Medicare beneficiaries to continue accessing healthcare through telehealth; more resources to enhance testing and contact tracing in underserved communities; opposing waivers from IDEA and the Rehab Act; and better data collection on the impact of COVID-19 on people with disabilities. -H.R. 6420/S. 3652 All Dependents Count Act, support passage. -H.R. 6680/S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305/S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage. -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless. -H.R. 2093/S. 1028, STATES Act, support passage. -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage. -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage.
EPILEPSY FOUNDATION via EPILEPSY FOUNDATION
2020 · first_quarter · Q1
-Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2021, support funding for epilepsy programs and research including $11.5 million for the CDCs Epilepsy program, $44.7 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System. -Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2021, support robust funding for the Food & Drug Administration. -Defense Appropriations Act, 2021, support robust funding for the Congressionally Directed Medical Research Programs.
-H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, support funding for agencies like the NIH, FDA and CDC to research, better treat and raise awareness and education about COVID-19, as well as support providing authority to relax restrictions in Medicare for telehealth services and reimbursement. -H.R. 6201, Families First Coronavirus Response Act, support various provisions relevant to people with epilepsy including increased federal support for state Medicaid programs; funding for agencies to research, better treat and raise awareness and education about COVID-19; expansion of paid sick leave and paid family and medical leave; and free COVD-19 testing regardless of insurance type. -H., CR. 748, CARES Act, support various provisions relevant to people with epilepsy and nonprofit support including access of up to a 90-day supply of medications through the pandemic; funding for agencies to research, better treat and raise awareness and education about COVID-19; prohibiting waivers of the Individuals with Disabilities Education Act (IDEA) and providing funding to ensure that special education needs are met through the pandemic; eligibility of Social Security beneficiaries for Economic Impact Payments and payments for Social Security beneficiaries without filing tax returns; grants to providers of Home and Community-Based Services; and allowing 501(c)(3) organizations and organizations that provide Medicaid services to apply for small business loans. -H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3, Elijah Cummings Lower Drug Costs Now Act, support specific provisions such as an out-of-pocket cap in Medicare Part D and addition of language to ban the use of QALYs -H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -S. 2543, the Prescription Drug Pricing Reduction Act of 2019, support specific provisions such as an out-of-pocket cap in Medicare and improvements to the Medicaid Drug Rebate Program, as well as permanent authorization of the Money Follows the Person program. (Nicole and I did a bunch of these visits together since the two issues got linked). -S. 1895, Lower Health Care Costs Act, support provisions to increase transparency and address anticompetitive practices in the prescription drug market -H.R. 712, VA Medicinal Cannabis Research Act, support addition of epilepsy -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -FDA-2019-N-1428, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, support preservation of meaningful access to cannabis and cannabis-derived products, including CBD tinctures with therapeutic levels of the cannabinoid, and creation of a regulatory framework that ensures that there is consistency in available products, manufacturing, safety, testing, and labeling standards, and increases the availability of important information such as potential side effects and drug interactions so that consumers and practitioners may be better informed -H.R. 2035/S. 995, Lifespan Respite Reauthorization Act, support passage.
EPILEPSY FOUNDATION via EPILEPSY FOUNDATION
2019 · fourth_quarter · Q4
-H.R. 4378, Continuing Appropriations Act, 2020, and Health Extenders Act of 2019, support passage. -H.R. 3055, Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019, support passage. -H.R. 1865, Further Consolidated Appropriations Act, 2020, support passage including supporting specific provisions including $9.5 million for the CDCs Epilepsy program, $41.7 billion for the NIH, $3.16 billion for the FDA, 10 year reauthorization of the Patient-Centered Outcomes Research Institute (PCORI) and 5 month extension of Money Follows the Person and spousal impoverishment.
-H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3, Elijah Cummings Lower Drug Costs Now Act, support specific provisions such as an out-of-pocket cap in Medicare Part D and addition of language to ban the use of QALYs -HR 3630, the No Surprises Act; S 1895, the S. 1895, Lower Health Care Costs Act; S 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -S. 2543, the Prescription Drug Pricing Reduction Act of 2019, support specific provisions such as an out-of-pocket cap in Medicare and improvements to the Medicaid Drug Rebate Program. -S. 1895, Lower Health Care Costs Act, support provisions to increase transparency and address anticompetitive practices in the prescription drug market -H.R. 712, VA Medicinal Cannabis Research Act, support addition of epilepsy -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -FDA-2019-N-1428, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, support preservation of meaningful access to cannabis and cannabis-derived products, including CBD tinctures with therapeutic levels of the cannabinoid, and creation of a regulatory framework that ensures that there is consistency in available products, manufacturing, safety, testing, and labeling standards, and increases the availability of important information such as potential side effects and drug interactions so that consumers and practitioners may be better informed -H.R. 2035/S. 995, Lifespan Respite Reauthorization Act, support passage.
EPILEPSY FOUNDATION via EPILEPSY FOUNDATION
2019 · third_quarter · Q3
-H.R. 3877, Bipartisan Budget Act, support raising budget caps -H.R. 4378, Continuing Resolution Act, support -H.R. 2740, FY 2020 Labor, Health and Human Services and Education Appropriations Act, support $11.5 million for the Centers for Disease Controls National Center for Chronic Disease Prevention and Health Promotion; $41.6 billion for the National Institutes of Health; $8.56 billion for the Health Resources & Services Administrations (HRSA) discretionary budget authority; $46 million for the Agency for Healthcare Research and Quality (AHRQ); support $20 million for the Lifespan Respite Care Program; and a $1.7 billion increase over 2019 levels for the Individuals with Disabilities Education Act. -H.R. 2968, FY Defense Appropriations Act, support continued funding for the Congressionally Directed Medical Research Program (CDMRP).
-H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 712, VA Medicinal Cannabis Research Act, support addition of epilepsy -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -FDA-2019-N-1428, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, support preservation of meaningful access to cannabis and cannabis-derived products, including CBD tinctures with therapeutic levels of the cannabinoid, and creation of a regulatory framework that ensures that there is consistency in available products, manufacturing, safety, testing, and labeling standards, and increases the availability of important information such as potential side effects and drug interactions so that consumers and practitioners may be better informed -H.R. 2328/H.R. 3439, support reauthorization of the Patient-Centered Outcomes Research Institute (PCORI) for a minimum of 7 years -HHS Docket No. HHS-OCR-2019-0007, RIN 0945-AA11, oppose weakening of anti-discrimination provisions of Section 1557 of the Affordable Care Act -H.R. 3, Lower Drug Costs Now Act, support specific provisions that are relevant to the epilepsy community such as an out-of-pocket cap in Medicare Part D and addition of language to ban the use of QALYs -FY 2020 Revisions to Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment Policies (CMS-1715-P) and CY 2020 Medicare Hospital Outpatient Prospective Payment System Proposed Rule (CMS-1717-P), expressed concern with reductions in the values for the new long-term EEG (electroencephalograph) and video EEG (VEEG) professional and technical service codes and urge appropriate values be assigned -RIN:0938-AT41, oppose proposed rescission of the existing regulations on Medicaid equal access
EPILEPSY FOUNDATION via EPILEPSY FOUNDATION
2019 · second_quarter · Q2
-FY 2020 Labor, Health and Human Services and Education Appropriations Act, support $11.5 million for the Centers for Disease Controls National Center for Chronic Disease Prevention and Health Promotion; $41.6 billion for the National Institutes of Health; $8.56 billion for the Health Resources & Services Administrations (HRSA) discretionary budget authority; $46 million for the Agency for Healthcare Research and Quality (AHRQ); support $20 million for the Lifespan Respite Care Program; and a $1.7 billion increase over 2019 levels for the Individuals with Disabilities Education Act. -H.R. 2968, FY Defense Appropriations Act, support continued funding for the Congressionally Directed Medical Research Program (CDMRP).
-Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses (CMS-4180-P), oppose weakening of Medicares Six Protected Classes and urge proposed rule to be rescinded -S. 691, Medicare Extra Rx HELP Act, support passage -H.R. 2279, Safe Step Act, support passage -H.R. 1839, Medicaid Services Investment and Accountability Act, support passage of the ACE Kids Act, reauthorization of Money Follows the Person and extension of spousal impoverishment protections - H.R. 2035 / S. 995, Lifespan Respite Care Reauthorization Act, support passage -HR 1385, SAVE Act, support passage -HR 1386, ENROLL Act, support passage -HR 1425, State Health Care Premium Reduction Act, support passage -HR 987, MORE Health Education Act, support passage -HR 986/S. 466, Protecting Americans with Preexisting Conditions Act, support passage -HR 1010, support passage -H.R. 712, VA Medicinal Cannabis Research Act, support addition of epilepsy -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -Regulation of products containing cannabis or cannabis-derived compounds -Support reauthorization of the Patient-Centered Outcomes Research Institute (PCORI)
EPILEPSY FOUNDATION via EPILEPSY FOUNDATION
2019 · first_quarter · Q1
-FY 2020 Labor, Health and Human Services and Education Appropriations Act, support $11.5 million for the Centers for Disease Controls National Center for Chronic Disease Prevention and Health Promotion; $41.6 billion for the National Institutes of Health; $8.56 billion for the Health Resources & Services Administrations (HRSA) discretionary budget authority; $46 million for the Agency for Healthcare Research and Quality (AHRQ); and a $1.7 billion increase over 2019 levels for the Individuals with Disabilities Education Act.
-Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses (CMS-4180-P), oppose weakening of Medicares Six Protected Classes and urge proposed rule to be rescinded -S. 691, Medicare Extra Rx HELP Act, support passage -H.R. 2279, Safe Step Act, support passage -H.R. 1839, Medicaid Services Investment and Accountability Act, support passage of the ACE Kids Act, reauthorization of Money Follows the Person and extension of spousal impoverishment protections - H.R. 2035 / S. 995, Lifespan Respite Care Reauthorization Act, support passage -HR 1385, SAVE Act, support passage -HR 1386, ENROLL Act, support passage -HR 1425, State Health Care Premium Reduction Act, support passage -HR 987, MORE Health Education Act, support passage -HR 986/S. 466, Protecting Americans with Preexisting Conditions Act, support passage -HR 1010, support passage -H.R. 712, VA Medicinal Cannabis Research Act, support addition of epilepsy
EPILEPSY FOUNDATION via EPILEPSY FOUNDATION
2018 · fourth_quarter · Q4
-H.R. 620, ADA Education and Reform Act, oppose passage.
None this quarter
-HR 7217, the IMPROVE Act, support inclusion and passage of the ACE Kids Act, reauthorization of Money Follows the Person and extension of spousal impoverishment protections. -H.R. 2077, Restoring the Patient's Voice Act, support passage. -CMS-4180-P, Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses, oppose weakening of Medicare's Six Protected Classes policy. -H.R. 2, Agriculture Improvement Act, educate about implications of hemp and hemp-derived cannabidiol (CBD) provisions.
EPILEPSY FOUNDATION via EPILEPSY FOUNDATION
2018 · third_quarter · Q3
--H.R. 6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019, support funding for the National Institutes of Health, Centers for Disease Control & Prevention, Special Projects of Regional and National Significance and the National Neurological Conditions Surveillance System.
-S. 2553, Know the Lowest Price Act of 2018, support passage. -S. 2554, Patient Right to Know Drug Prices Act, support passage. -H.R. 2077, Restoring the Patient's Voice Act, support passage.
-H.R. 620, ADA Education and Reform Act, oppose passage.
EPILEPSY FOUNDATION via EPILEPSY FOUNDATION
2018 · second_quarter · Q2
Health care reform, Medicare, Medicaid, access to care
ADA, employment discrimination, access to education, ending stigma surrounding epilepsy, disability rights
NIH, CDC, FDA and health care/public health appropriations
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Equal Employment Opportunity Commission (EEOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE, White House Office
EPILEPSY FOUNDATION via EPILEPSY FOUNDATION
2018 · first_quarter · Q1
Health care reform, Medicare, Medicaid, access to care
ADA, employment discrimination, access to education, ending stigma surrounding epilepsy, disability rights
NIH, CDC, FDA and health care/public health appropriations
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Equal Employment Opportunity Commission (EEOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE, White House Office
-H.R. 7614, Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2021, support funding for epilepsy programs and research including $11.5 million for the CDCs Epilepsy program, $44.7 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System and $10 million for Lifespan Respite Care Program. -H.R. 7610, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2021, support robust funding for the Food & Drug Administration. -H.R. 7617, Defense Appropriations Act, 2021, support robust funding for the Congressionally Directed Medical Research Programs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office